Neurones SA · TURQUOISE:NROP

Neurones SA financial statements

Neurones SA's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in EUR

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue857.2M810.4M741.2M665.4M579.9M524.5M510.1M490.1M485.0M446.8M
Cost of revenue767.1M421.6M394.4M583.7M510.1M455.9M293.5M292.1M298.9M281.5M
Gross profit90.0M388.8M346.8M81.6M69.7M68.6M216.5M198.0M186.1M165.3M
Selling, general and administrative437.6M408.1M577.5M170.8M150.7M143.5M142.1M133.6M116.3M
Operating income75.6M77.9M75.9M72.9M61.6M51.9M53.7M46.0M44.9M42.5M
Depreciation and amortization18.0M17.7M15.9M8.52M7.53M16.0M15.3M7.90M8.42M7.74M
EBITDA93.6M95.6M91.8M81.4M69.1M67.8M69.0M53.9M53.3M50.2M
Interest expense1.20M1.65M1.43M1.70M966.0K1.02M1.21M548.0K278.0K344.0K
Income before tax85.1M88.1M80.8M72.9M61.8M53.6M53.8M47.6M47.8M44.9M
Income tax23.2M24.9M22.2M21.1M18.8M18.6M18.7M18.0M16.2M15.9M
Net income52.1M52.6M49.4M44.2M37.7M30.9M30.8M26.0M27.3M25.2M
Earnings per share, basic2.142.172.041.831.561.271.271.071.121.04
Earnings per share, diluted2.142.162.031.821.56

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents340.8M326.5M297.8M272.1M265.2M143.5M218.6M174.9M154.6M141.4M
Short-term investments276.1M-65.0K195.3M169.6M123.1M120.4M-113.0K-102.0K11.3M
Receivables261.6M257.7M243.0M227.8M195.8M174.4M159.6M171.4M158.2M146.0M
Inventory18.0K267.0K709.0K353.0K887.0K1.31M385.0K278.0K891.0K245.0K
Current assets608.5M588.1M545.8M506.6M464.1M449.1M412.8M383.4M346.4M318.6M
Property, plant and equipment29.4M28.1M24.8M16.0M12.9M46.6M47.1M16.2M16.2M14.5M
Goodwill60.9M56.5M51.7M45.0M44.4M42.1M39.9M39.9M40.0M42.4M
Total assets749.0M725.7M676.1M616.2M567.8M549.9M510.1M449.1M411.7M385.6M
Accounts payable235.4M234.5M210.0M189.2M169.9M32.7M31.0M31.3M29.4M26.2M
Current liabilities250.1M252.7M228.9M207.1M184.6M161.4M156.4M151.7M142.1M145.2M
Long-term debt760.0K2.05M1.51M110.0K204.0K371.0K3.00K2.00K240.0K862.0K
Total debt760.0K2.05M44.0M35.6M35.3M34.2M31.6M375.0K1.38M2.69M
Total liabilities284.2M289.5M266.3M240.6M214.9M190.8M182.8M153.2M143.6M147.2M
Shareholders' equity400.0M378.1M355.8M330.6M311.6M322.6M297.2M266.8M243.0M217.0M
Shares outstanding28.9M24.3M24.3M24.3M24.2M24.3M24.3M24.3M24.3M24.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations71.3M84.4M72.1M55.0M64.5M67.3M61.3M31.1M23.3M21.1M
Capital spending-10.4M-12.0M-18.0M-10.6M-6.58M-7.19M-7.89M-6.95M-8.96M-8.55M
Free cash flow70.3M72.3M54.1M44.4M57.9M60.1M53.4M24.1M14.3M12.5M
Cash from investing-21.2M-19.7M-21.6M-12.3M-10.6M-8.01M-8.15M-9.43M-9.87M-11.2M
Cash from financing-35.6M-34.5M-27.1M-36.1M-55.4M-11.1M-9.36M-1.04M180.0K-82.0K
Dividends paid-31.6M-29.1M-26.6M-24.2M-48.4M-4.84M-1.46M-1.46M-1.45M-1.45M
Share buybacks-316.0K-28.0K57.0K-107.0K-7.07M-1.23M01.25M
Change in cash14.5M30.2M23.4M6.64M-1.55M48.0M43.9M20.4M13.3M9.79M